CN101062054A - Medicine for curing wound - Google Patents
Medicine for curing wound Download PDFInfo
- Publication number
- CN101062054A CN101062054A CNA2007100557392A CN200710055739A CN101062054A CN 101062054 A CN101062054 A CN 101062054A CN A2007100557392 A CNA2007100557392 A CN A2007100557392A CN 200710055739 A CN200710055739 A CN 200710055739A CN 101062054 A CN101062054 A CN 101062054A
- Authority
- CN
- China
- Prior art keywords
- grams
- examples
- medicine
- wound
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to an externally-used medicament for treating trauma which is prepared from the following medicinal herbs (by weight ratio): sulfamethoxazole 30-40 parts, berberine 5-15 parts, calcined gypsum 15-30 parts, zinc oxide powder 15-20 parts.
Description
Technical field
The invention belongs to a kind of external used medicine for the treatment of wound.
Background technology
Burn, wound and other surgical wound are by modern times or traditional therapy treatment the time, and with the debridement of trauma wounds operative incision, stitching, 1-2 takes out stitches after week usually, and infection rate accounts for 40%-60%, and various liniment curative effects are not good enough.Particularly treatment is burnt, the application common drug, and 1 degree burn needs 2-3 days transference cures, shallow 2 degree burns need to heal about 2 weeks, and dark 2 degree burns need 3-4 week healing, and 3 degree burns need 2-4 week eschar to come off, wound healing time is indefinite when granulation occurring, and the healing of need making skin graft has at last influenced therapeutic effect.
Summary of the invention
The invention provides a kind of medicine for the treatment of wound, to solve the not good problem of therapeutic effect that present common medicine exists.The technical scheme that the present invention takes is: be to be made by the crude drug of following ratio of weight and number:
Sulfamethoxazole 30-40 part;
5～15 parts of berberines;
Gypsum Fibrosum preparata 15-30 part;
Oxide powder and zinc 15-20 part.
The present invention also can add the adjuvant of following weight portion: 300～500 parts of 0.01% ethacridines, and mix well with major ingredient and to make solvent.
The present invention also can add the adjuvant of following weight portion: 150～200 parts of vaseline oil or fish liver oil emulsions, and mix well with major ingredient and to make unguentum.
The advantage of medicine of the present invention is, can soften blood crusts, eschar by bacteriostasis and sterilization, the drain evacuation of pus, dispel pus tongue, purulent core and slough, penetration is strong, easily absorbed by human tissue cell, drug action is strong, is applicable to that dark 2 degree, 3 degree burn and scald injure the more disease treatment of the surgical infections such as soft tissue defects, severe infections and cureless ulcer of deep layer.
During the treatment wound, this medicine of application then need not sewed up, and does not have and infects, and can cure substantially in 12 hours, cures fully in 48-96 hour.When burn treatment can make for 1 degree burn a few hours painlessly promptly heal, and shallow 2 degree burns only need 8 drug of topical application to cure fully.Preventing from scar only has pigmentation, and dark 2 degree burn treatings are cured the healing fully within 5 weeks of 3 degree small-area burns about with 2 weeks fully.And do not need skin-grafting, large-area burns are not having the utmost point in particular cases, can cure at the 7-8 time-of-week.
The specific embodiment
The preparation of embodiment 1 solvent of the present invention
Sulfamethoxazole 30 grams;
Berberine 5 grams;
Gypsum Fibrosum preparata 15 grams;
Oxide powder and zinc 15 grams;
0.01% ethacridine, 300 grams.
Mix well the above-mentioned raw materials medicine is mixed.
The preparation of embodiment 2 solvents of the present invention
Sulfamethoxazole 35 grams;
Berberine 10 grams;
Gypsum Fibrosum preparata 25 grams;
Oxide powder and zinc 17 grams;
0.01% ethacridine, 400 grams.
The preparation of embodiment 3 solvents of the present invention
Sulfamethoxazole 40 grams;
Berberine 15 grams;
Gypsum Fibrosum preparata 30 grams;
Oxide powder and zinc accounts for 20 grams;
0.01% ethacridine, 500 grams.
The preparation of embodiment 4 unguentum of the present invention
Sulfamethoxazole 30 grams;
Berberine 5 grams;
Gypsum Fibrosum preparata 15 grams;
Oxide powder and zinc 15 grams;
Vaseline oil 150 grams.
The above-mentioned raw materials medicine is mixed well.
The preparation of embodiment 5 unguentum of the present invention
Sulfamethoxazole 35 grams;
Berberine 10 grams;
Gypsum Fibrosum preparata 25 grams;
Oxide powder and zinc 17 grams;
Vaseline oil 180 grams.
The preparation of embodiment 6 unguentum of the present invention
Sulfamethoxazole 40 grams;
Berberine 15 grams;
Gypsum Fibrosum preparata 30 grams;
Oxide powder and zinc accounts for 20 grams;
Fish liver oil emulsion 200 grams.
Clinical practice example report of the present invention.
One, physical data
The sick kind: burn and scald 25 examples, operative incision and wound 48 examples, trauma infection contamination and other infect 27 examples, comprising diabetics 3 examples; Totally 100 examples.
Sex: male's 50 examples, women's 50 examples, totally 100 examples.
Age distribution: 1～10 years old, 14 examples; 11～20 years old, 11 examples; 21～30 years old, 24 examples; 31～40 years old, 23 examples; 41～50 years old, 8 examples; 51～60 years old, 11 examples; 61～80 years old, 9 examples.
Two, the course of treatment
The course of treatment: wound 24～96 hours, 39 examples; 5～20 days, 7 examples; 21～35 days, 2 examples; Trauma infection contamination and other: 1～2 week, 15 examples; 2～3 weeks, 4 examples; 3～4 weeks, 4 examples; More than 4～7 weeks, 4 examples.
Burn: shallow II degree, 3～7 days, 15 examples, dark II degree 24～35 days, 7 examples, III degree 120～195 days, 3 examples.
Three, administrated method
Be applied directly to the affected part, every day or the next day change dressings once.
Four, whom efficacy determination marks: wound and wound surface do not have sense of discomfort.
Five, therapeutic effect: cure rate 100%, no infection rate 100%.
Conclusion: Drug therapy wound of the present invention has the obvious treatment effect, its composition that contains has antiinflammatory, antibacterial, repair tissue cell, enhance metabolism, penetration is organized cell by force, rapidly and absorbs and can alleviate edema and ooze out, and promotes wound and wound surface quickly-healing.Have the advantages that hemostasis and pain-relieving convergence, prevention are oozed out, can putrefaction-removing granulation-promoting, promote healing, shorten the course of treatment.In clinical use, find no toxic and side effects and anaphylaxis.
Claims (3)
1, a kind of medicine for the treatment of wound is characterized in that it is to be made by the crude drug of following ratio of weight and number:
Sulfamethoxazole 30-40 part;
5～15 parts of berberines;
Gypsum Fibrosum preparata 15-30 part;
Oxide powder and zinc 15-20 part.
2, the medicine of treatment wound as claimed in claim 1 is characterized in that also can adding the adjuvant of following weight portion: 300～500 parts of 0.01% ethacridines.
3, the medicine of treatment wound as claimed in claim 1 is characterized in that also can adding the adjuvant of following weight portion: 150～200 parts of vaseline oil or fish liver oil emulsions.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100557392A CN101062054A (en) | 2007-06-08 | 2007-06-08 | Medicine for curing wound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100557392A CN101062054A (en) | 2007-06-08 | 2007-06-08 | Medicine for curing wound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101062054A true CN101062054A (en) | 2007-10-31 |
Family
ID=38963469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100557392A Pending CN101062054A (en) | 2007-06-08 | 2007-06-08 | Medicine for curing wound |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101062054A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579500A (en) * | 2012-02-24 | 2012-07-18 | 北京市肛肠医院 | Compound cod-liver oil ointment as well as preparation method and application thereof |
| CN103463199A (en) * | 2012-06-07 | 2013-12-25 | 林胜杰 | Composition for subcutaneous tissue trauma |
| CN106727621A (en) * | 2016-11-22 | 2017-05-31 | 郑州仁宏医药科技有限公司 | A kind of Western medicine powder for treating toothache |
| CN108451978A (en) * | 2018-04-24 | 2018-08-28 | 杨延新 | A kind of ointment for scald |
-
2007
- 2007-06-08 CN CNA2007100557392A patent/CN101062054A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579500A (en) * | 2012-02-24 | 2012-07-18 | 北京市肛肠医院 | Compound cod-liver oil ointment as well as preparation method and application thereof |
| CN103463199A (en) * | 2012-06-07 | 2013-12-25 | 林胜杰 | Composition for subcutaneous tissue trauma |
| CN106727621A (en) * | 2016-11-22 | 2017-05-31 | 郑州仁宏医药科技有限公司 | A kind of Western medicine powder for treating toothache |
| CN108451978A (en) * | 2018-04-24 | 2018-08-28 | 杨延新 | A kind of ointment for scald |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1915371A (en) | Medication for treating burn and scald, frostbite, and preparation method | |
| CN101062054A (en) | Medicine for curing wound | |
| CN1827144A (en) | Externally applied Chinese medicinal mixture for treating onychomycosis | |
| CN101049337A (en) | Medication for curing furuncle, sore, and carbuncle, and preparation method | |
| CN1839898A (en) | Scar-free wet ointment for scald and burn and its preparation method | |
| CN1246021C (en) | Non-scar plaster for treating trauma and its preparing process and usage | |
| CN1259052C (en) | Medicinal composition for treating burn and scald and preparing method | |
| CN1279952C (en) | Medicine for treating burns and scalds | |
| CN1528413A (en) | Medicine for treating bum, empyrosis and bedsore | |
| CN1939470A (en) | Chinese medicinal plaster with analgetic, hemostatic repercussive and sore-arresting functions | |
| CN1242773C (en) | Medicine for treating skin wound and its processing method | |
| CN100346814C (en) | Powder for curing muscle ulceration and process for preparing the same | |
| CN1286497C (en) | Plaster for treating shank sore | |
| Koenig et al. | Healing wounds with honey | |
| CN101028397A (en) | Medicinal composition for treating traumatic skin coloboma, burn and scald and its production | |
| CN1270748C (en) | Chinese medicinal composition for treating sore and wound infection | |
| CN104138522A (en) | Crack healing ointment | |
| MX2013004077A (en) | Pharmaceutical composition based on centella asiatica (hydrocotyle asiatica l.) for treating lower limbs ulcers. | |
| CN1247216C (en) | External used Chinese medicinal ointment for scald and its preparation | |
| CN103083382A (en) | Radix angelicae skin repairing pain relieving powder | |
| CN101869578B (en) | External liniment for drawing pus out and diminishing inflammation | |
| CN108635362B (en) | Pharmaceutical composition for treating diabetic foot | |
| CN101869623B (en) | Medicament for treating trichoepithelioma and preparation method thereof | |
| CN1903214A (en) | Ointment containing red precipitate | |
| CN101040904A (en) | Drug for scald and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20071031 |